Physician profile
Rodney S Badger
NPI 1003874439
$10,627.61
in general payments reported to CMS, 2019-2025
29 companies · $466 in 2025
The $466 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,789 · 2020: $1,253 · 2021: $2,139 · 2022: $1,759 · 2023: $2,304 · 2024: $918 · 2025: $466.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,576 · Consulting Fee: $1,000 · Education: $69.21 · Travel and Lodging: $43.12.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,575.75 |
| Consulting Fee | $1,000.00 |
| Education | $69.21 |
| Travel and Lodging | $43.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merit Medical Systems INC | $2,176.72 | 2021-2023 | Impress Catheters |
| Medtronic, INC. | $1,236.49 | 2021-2024 | Resolute Onyx, Micra, Cobalt Dr Mri Surescan |
| Abiomed | $1,156.68 | 2019-2025 | Impella |
| Medtronic Vascular, INC. | $1,095.18 | 2019-2020 | |
| Boston Scientific Corporation | $851.38 | 2019-2025 | General - Structural Heart, Avvigo Guidance System, General - Therapies |
| Inari Medical, INC. | $764.14 | 2022-2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Biotronik INC. | $668.81 | 2019-2025 | Biomonitor |
| Shockwave Medical, INC | $428.61 | 2022-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abbott Laboratories | $367.49 | 2021-2025 | Aveir, Assurity |
| Bard Peripheral Vascular, INC. | $305.64 | 2020 | |
| Edwards Lifesciences Corporation | $292.17 | 2024 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| E.R. Squibb & Sons, L.L.C. | $202.44 | 2021-2023 | Camzyos |
| Cardiovascular Systems INC. | $142.77 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $115.85 | 2022 | |
| Amgen INC. | $109.16 | 2021-2022 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $103.40 | 2020-2025 | Lifevest |
| Merck Sharp & Dohme LLC | $70.31 | 2021-2023 | Verquvo |
| Novartis Pharmaceuticals Corporation | $66.50 | 2021-2023 | |
| Philips North America LLC | $65.72 | 2021 | |
| Glaxosmithkline, LLC. | $62.38 | 2022 | |
| Penumbra, INC. | $60.93 | 2019-2024 | Indigo System |
| Janssen Pharmaceuticals, INC | $60.12 | 2021-2022 | |
| Terumo Medical Corporation | $57.00 | 2019 | |
| Transit Scientific, LLC | $51.54 | 2021-2022 | |
| Actelion Pharmaceuticals US, INC. | $33.48 | 2023 | Uptravi, Opsumit |
| Novo Nordisk INC | $29.52 | 2021-2022 | |
| Impulse Dynamics (USA) INC. | $20.18 | 2021 | |
| Pfizer INC. | $17.38 | 2021 | |
| Amarin Pharma, INC. | $15.62 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rodney Badger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.